CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
about
Tying malaria and microRNAs: from the biology to future diagnostic perspectivesGenetic polymorphisms linked to susceptibility to malariaEmerging roles for platelets as immune and inflammatory cellsPharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malariaGlucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malariaReduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β-methasone nanodrug.2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria.CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria.Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malariaIRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malariaCXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications.Changes in the levels of cytokines, chemokines and malaria-specific antibodies in response to Plasmodium falciparum infection in children living in sympatry in Mali.Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature.Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in TanzaniaEarly prediction of cerebral malaria by (1)H NMR based metabolomicsImprovement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria.The role of chemokines in severe malaria: more than meets the eye.Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria.The mechanistic, diagnostic and prognostic utility of biomarkers in severe malaria.Pathogenic CD8+ T cells in experimental cerebral malaria.The immunological balance between host and parasite in malaria.Cytokines and Chemokines in Cerebral Malaria Pathogenesis.The role of chemokines and their receptors during protist parasite infections.Monocyte- and Neutrophil-Derived CXCL10 Impairs Efficient Control of Blood-Stage Malaria Infection and Promotes Severe Disease.Effects of Pregnancy-associated Malaria on T Cell Cytokines in Cameroonian Women.Adjunctive therapy for severe malaria: a review and critical appraisal.Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration.Atypical activation of dendritic cells by Plasmodium falciparum.Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.CXCL10 stabilizes T cell-brain endothelial cell adhesion leading to the induction of cerebral malaria.Platelets kill circulating parasites of all major Plasmodium species in human malaria
P2860
Q26765405-6FEB52F7-7602-4DFC-BA94-C90F6F12A845Q26860744-612B0DB6-9CBF-47FF-818B-BE7ABDE58FFCQ27016553-88916759-3798-4CF8-B051-EAD95F08B6FAQ28486022-CADD9F99-FE84-4BA0-BB43-A355CB587436Q28535601-6AA3C085-E15C-4466-A457-0BFCB441D5B5Q34003170-703CBC17-1C3D-4189-8AA1-31409EACA474Q34674936-1FDA9176-623A-4C21-8682-7E8936CF687FQ34854215-15B29A0F-90F0-4502-9BF8-39405CE13D71Q35069542-8D9AC9C9-1200-406F-B20A-32594CF9BB08Q35151929-E4C094E6-91CD-429B-9894-0A0FA2E4D641Q35187600-F5745A2E-C978-489C-A243-8608838E24D9Q35469531-9C0AD233-0C72-4F9A-BA84-FEA1DC1D7997Q36007103-6069AFA9-43AE-4C81-8F7A-E5714C03E12EQ36209383-54439DD1-0B70-43C1-9DD2-9790E57718F8Q36210506-86B5D1C3-9A66-4083-B4EB-4B1DB9BE82DEQ36776006-18C860FC-2F30-4E26-8706-528425511FF0Q36790143-50E41ECB-D8A8-41BC-8903-D0AD967B711FQ37152937-977E3BA1-ED91-4F6B-8B77-B69F6C3EFF26Q37532357-A3D944A8-5812-47EB-99FC-08615953D676Q37643882-FA5A3006-F28A-4563-9C00-0328532978B9Q37655274-F8756EA9-B2E3-47FE-9FED-F37DBB2B20E7Q37734218-70FFE844-ADD1-4728-9DC4-8EC03021D23EQ38111808-A63A7CA5-03FD-4C37-AF40-085646AFED58Q38378859-4F651ABC-4553-44A5-AFFA-30F116A7A167Q38666558-19431850-55EF-4AD4-B16E-971250A27A9EQ40107124-E42F75C0-6045-4FEB-AC6F-BD43BA5DE9DBQ40515876-583C5E38-5281-493E-B438-8AA7EFED9DB3Q40850222-CEAE67D7-EB1B-4E91-81AA-362147729003Q41452072-A5AB1BA0-2DA7-471C-8FA3-426EA1537B70Q47716363-B304FF37-2E87-4D69-A390-AC87EAFE3805Q47966325-4E0ABCB3-F8F4-4245-B0CB-641B4E7E9AC5Q48017396-973385DD-27C7-4BD2-9876-37B3299338AFQ52691003-61DDC0FD-4FA3-4CDC-A5B7-EAA0783D6EA5Q54232946-B1088C82-417F-4BA6-9E1F-2A380004AB7FQ56358763-A9B61240-5125-407B-B7F0-A0EE3F26A92E
P2860
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@ast
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@en
type
label
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@ast
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@en
prefLabel
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@ast
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@en
P2093
P356
P1433
P1476
CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
@en
P2093
Aditya P Dash
Avinash C Nagpal
Christina E Roberts
Jonathan K Stiles
Mrigendra P Singh
Nana O Wilson
Naomi Lucchi
Neeru Singh
Pradeep K Joel
Vidhan Jain
P356
10.1155/2011/828256
P577
2011-01-01T00:00:00Z